Summary
The pharmacokinetic values of d,l-leucovorin and l-leucovorin were compared in eight healthy volunteers following oral administration of 25 mg d,l-leucovorin and 12.5 mg l-leucovorin. Serum levels of l-5-for-myltetrahydrofolate, l-5-methyltetrahydrofolate, and total reduced folates were measured by an established microbiological method. Pharmacokinetic data for both preparations were consistent with those previously reported for d,l-leucovorin, with essentially complete first pass metabolism to l-5-methyltetrahydrofolate, the active metabolite.
No differences were found between the two preparations in serum concentrations of active folate fractions, AUC, or Cmax, or in clearance and volume of distribution estimates.
These data suggest that after administration of 25 mg of d,l-leucovorin, the d-diastereoisomer has no significant effect on the standard pharmacokinetic measurements of the active l-folates.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Mathews RF (1984) Methionine biosynthesis. In: Blakley RL, Benkovic SJ (eds) Folates and pterins. Vol 1. Chemistry and biochemistry of folates. Wiley, New York, pp 497–554
Santi DV, Danenberg P (1984) Folates and pyrimidine nucleotide synthesis. In: Blakley RL, Benkovic SJ (eds) Folates and pterins. Vol 1. Chemistry and biochemistry of folates. Wiley, New York, pp 345–398
Jolivet J, Cowan KH, Curt GA, Clendeninn JN, Chabner BA (1983) The pharmacology and clinical use of methotrexate. New Engl J Med 309: 1094–1104
Chabner BA (1982) Methotrexate. In: Chabner B (ed) Pharmacologic principles of cancer treatment. Saunders, Philadelphia, pp 229–255
Allegra CJ, Baram J, Boarman D, Drake JC, Chabner BA (1988) Investigation into the mechanism of reversal of methotrexate induced cytotoxicity by leucovorin in human breast cancer cell line. Proc Am Assoc Cancer Res 29: 284
Matherly LH, Barlowe CK, Goldman ID (1986) Antifolate polyglutamation competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue 11210 cells. Cancer Res 46: 588–593
Goldin A (1978) Studies with high dose methotrexate: historical perspective. Cancer Treat Rep 62: 307–312
Ackland SP, Schilsky RL (1987) High-dose methotrexate: a critical reappraisal. J Clin Oncol 5: 2017–2031
Cosulich DB, Smith JM, Hultquist ME, Parker RP (1952) Chemistry of leucovorin. J Am Chem Soc 74: 3252–3263
Cosulich DB, Smith JM, Broquist RM. Diastereomers of leucovorin (1952) J Am Chem Soc 74: 4215–4216
Bertrand R, Jolivet J (1988) The natural and unnatural isomers of leucovorin: aspects of their cellular pharmacology. Adv Exp Med Biol 244: 13–24
Straw JA, Szapary D, Wynn WT (1984) Pharmacokinetics of the diastereomers of leucovorin after oral and intravenous administration in normal subjects. Cancer Res 44: 3114–3119
Wainer IM, Stiffen RM (1988) Direct resolution of the stereoisomers of leucovorin and 5-methyltetrahydrofolate using a bovine serum albumin high performance liquid chromatographic stationary phase coupled to an achiral phenyl column. J Chromatogr 424: 158–162
Zittoun J, Marquet J, Pilorget JJ, Tonetti C, De Gialluly E (1991) Comparative effect of 6S, 6R and 4RS leucovorin on methotrexate rescue and on modulation of 5-fluorouracil. Br J Cancer 63: 885–888
Sirotnak FM, Chello PL, Moccio DM (1979) Stereospecificity at carbon 6 of formyltetrahydrofolate as a competitive inhibitor of transport and cytotoxicity of methotrexate in vitro. Biochem Pharmacol 28: 2993–2997
Schilsky RL, Kae GE, Choi KE (1988) Uptake and biologic activity of the stereoisomers of leucovorin in human colon cancer cells. Proc Am Assoc Cancer Res 29: 500
Straw JA, Newman EM, Doroshow JH (1987) Pharmacokinetics of leucovorin after intravenous injection and constant intravenous infusion. NCI Monogr 5: 41–45
Waters AH, Mollin DL (1961) Studies on the folic acid activity of human serum. J Clin Path 14: 335
Zittoun R, Zittoun J (1970) Les anemies par carence en vitamine B12 et en acide folique. Problemes etiologiques et methodes d'investigation. Revue du Practicien 20: 573–597
McGuire BW, Sia LL, Haynes JD, Kisicki JC, Guterrez ML, Stokstad ELR (1987) Absorption kinetics of orally administered leucovorin calcium. NCI Monogr 5: 47–56
McGuire BW, Sia LL, Leese P, Guterrez ML, Stokstad ELR (1988) Pharmacokinetics of leucovorin calcium after intravenous, intramuscular and oral administration. Clin Pharm 7: 52–58
Greiner PO, Zittoun J, Marquet J, Cheron JM (1989) Pharmacokinetics of (−)-folinic acid after oral and intravenous administration of the racemate. Br J Clin Pharmacol 28: 289–295
Mehta BM, Gisolfi AL, Hutchison DJ, Nirenberg A, Kellick MG, Rosen G (1978) Serum distribution of citrovorin factor and 5-methyltetrahydrofolate following oral and IM administration of calcium leucovorin in normal adults. Cancer Treat Rep 62: 345–350
Sato JK, Moran RG (1984) Interaction of methotrexate and citrovorum factor at folyl polyglutamate synthetase. Proc Am Assoc Cancer Res 25: 312
White JC, Goldman ID (1979) Lack of stereospecificity at carbon 6 of methyltetrahydrofolate transport: possible relevance to rescue regiments with methotrexate and leucovorin. In: Kisliuk RL, Brown GM, (eds) Chemistry and biology of pteridines. Elsevier, Amsterdam New York, pp 625–627
Nixon PF (1979) Folinic acid pharmacokinetics and pharmacodynamics. Clin Exp Pharmacol Physiol Suppl 5: 35–41
Bleyer WA (1989) New vistas in cancer chemotherapy. Cancer Suppl 63: 995–1007
Schalhorn A, Kuhl M, Heil K, Wilmanns W (1990) Comparative pharmacokinetics of D,L-folinic acid and of the pure l-folinic acid. Proc Am Soc Clin Oncol 9: A253
Rustum YM, Zhang ZG, Frank C, Creaven PJ, Petrelli N (1991) Pharmacokinetics of the biologically active isomer, 6S-leucovorin in patients with advanced colorectal carcinoma. Proc Am Assoc Cancer Res 32: A1037
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zittoun, J., Tonelli, A.P., Marquet, J. et al. Pharmacokinetic comparison of leucovorin and levoleucovorin. Eur J Clin Pharmacol 44, 569–573 (1993). https://doi.org/10.1007/BF02440861
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02440861